| IC 35-48-2-10 |
NARCOTIC NEWS
Drug Law in Indiana IC 35-48-2-10
Drug Law in Indiana IC 35-48-2-10
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Schedule IV
Sec. 10. (a) The controlled substances listed in this section are included in
schedule IV.
(b) Narcotic drugs. Unless specifically excepted in a rule adopted by the board
or unless listed in another schedule, any material, compound, mixture, or
preparation containing any of the following narcotic drugs, or their salts
calculated as the free anhydrous base or alkaloid, in the following limited
quantities:
(1) Not more than 1 milligram of difenoxin (9618) and not less than 25
micrograms of atropine sulfate per dosage unit.
(2) Dextropropoxyphene (alpha-
(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-propionoxybut ane (9273).
(c) Depressants. Unless specifically excepted in a rule adopted by the board or
unless listed in another schedule, any material, compound, mixture, or
preparation which contains any quantity of the following substances, including
its salts, isomers, and salts of isomers whenever the existence of such salts,
isomers, and salts of isomers is possible within the specific chemical
designation:
Alprazolam (2882)
Barbital (2145)
Bromazepam (2748)
Camazepam (2749)
Carisoprodol
Chloral betaine (2460)
Chloral hydrate (2465)
Chlordiazepoxide (2744)
Clobazam (2751)
Clonazepam (2737)
Clorazepate (2768)
Clotiazepam (2752)
Cloxazolam (2753)
Delorazepam (2754)
Diazepam (2765)
Estazolam (2756).
Ethchlorvynol (2540)
Ethinamate (2545)
Ethyl loflazepate (2758)
Fludiazepam (2759)
Flunitrazepam (2763)
Flurazepam (2767)
Halazepam (2762)
Haloxazolam (2771)
Ketazolam (2772)
Loprazolam (2773)
Lorazepam (2885)
Lormetazepam (2774).
Mebutamate (2800).
Medazepam (2836).
Meprobamate (2820)
Methohexital (2264).
Methylphenobarbital (mephobarbital) (2250).
Midazolam (2884).
Nimetazepam (2837).
Nitrazepam (2834).
Nordiazepam (2838).
Oxazepam (2835).
Oxazolam (2839).
Paraldehyde (2585).
Petrichloral (2591).
Phenobarbital (2285).
Pinazepam (2883).
Prazepam (2764).
Quazepam (2881).
Temazepam (2925).
Tetrazepam (2886).
Triazolam (2887).
Zolpidem (Ambien) (2783).
(d) Fenfluramine. Any material, compound, mixture, or preparation which
contains any quantity of the following substances, including its salts, isomers
(whether optical, position, or geometric), and salts of such isomers, whenever
the existence of such salts, isomers, and salts of isomers is possible.
Fenfluramine (1670).
(e) Stimulants. Unless specifically excepted in a rule adopted by the board or
unless listed in another schedule, any material, compound, mixture, or
preparation which contains any quantity of the following substances having a
stimulant effect on the central nervous system, including its salts, isomers
(whether optical, position, or geometric), and salts of such isomers whenever
the existence of such salts, isomers, and salts of isomers is possible within
the specific chemical designation:
(1) Diethylpropion (1608).
(2) Mazindol (1605).
(3) Phentermine (1640).
(4) Pemoline (including organometallic complexes and chelates thereof)
(1530).
(5) Pipradrol (1750).
(6) SPA ((-)-1-dimethylamino-1,2-diphenylethane (1635).
(f) Other substances. Unless specifically excepted or unless listed in another
schedule, any material, compound, mixture, or preparation which contains any
quantity of the following substances including its salts:
(1) Pentazocine (9709).
(g) The board may except by rule any compound, mixture, or preparation
containing any depressant substance listed in subsection (b), (c), (d), (e), or (f)
from the application of any part of this article if the compound, mixture, or
preparation contains one (1) or more active medicinal ingredients not having a
depressant effect on the central nervous system, and if the admixtures are
included therein in
combinations, quantity, proportion, or concentration that vitiate the potential for
abuse of the substances which have a depressant effect on the central nervous
system.
As added by Acts 1976, P.L.148, SEC.7. Amended by Acts 1977, P.L.344,
SEC.2; Acts 1979, P.L.303, SEC.6; Acts 1981, P.L.170, SEC.5; P.L.333-1983,
SEC.4; P.L.77-1984, SEC.14; P.L.200-1987, SEC.12; P.L.288-2001, SEC.17;
P.L.8-2004, SEC.3.
schedule IV.
(b) Narcotic drugs. Unless specifically excepted in a rule adopted by the board
or unless listed in another schedule, any material, compound, mixture, or
preparation containing any of the following narcotic drugs, or their salts
calculated as the free anhydrous base or alkaloid, in the following limited
quantities:
(1) Not more than 1 milligram of difenoxin (9618) and not less than 25
micrograms of atropine sulfate per dosage unit.
(2) Dextropropoxyphene (alpha-
(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-propionoxybut ane (9273).
(c) Depressants. Unless specifically excepted in a rule adopted by the board or
unless listed in another schedule, any material, compound, mixture, or
preparation which contains any quantity of the following substances, including
its salts, isomers, and salts of isomers whenever the existence of such salts,
isomers, and salts of isomers is possible within the specific chemical
designation:
Alprazolam (2882)
Barbital (2145)
Bromazepam (2748)
Camazepam (2749)
Carisoprodol
Chloral betaine (2460)
Chloral hydrate (2465)
Chlordiazepoxide (2744)
Clobazam (2751)
Clonazepam (2737)
Clorazepate (2768)
Clotiazepam (2752)
Cloxazolam (2753)
Delorazepam (2754)
Diazepam (2765)
Estazolam (2756).
Ethchlorvynol (2540)
Ethinamate (2545)
Ethyl loflazepate (2758)
Fludiazepam (2759)
Flunitrazepam (2763)
Flurazepam (2767)
Halazepam (2762)
Haloxazolam (2771)
Ketazolam (2772)
Loprazolam (2773)
Lorazepam (2885)
Lormetazepam (2774).
Mebutamate (2800).
Medazepam (2836).
Meprobamate (2820)
Methohexital (2264).
Methylphenobarbital (mephobarbital) (2250).
Midazolam (2884).
Nimetazepam (2837).
Nitrazepam (2834).
Nordiazepam (2838).
Oxazepam (2835).
Oxazolam (2839).
Paraldehyde (2585).
Petrichloral (2591).
Phenobarbital (2285).
Pinazepam (2883).
Prazepam (2764).
Quazepam (2881).
Temazepam (2925).
Tetrazepam (2886).
Triazolam (2887).
Zolpidem (Ambien) (2783).
(d) Fenfluramine. Any material, compound, mixture, or preparation which
contains any quantity of the following substances, including its salts, isomers
(whether optical, position, or geometric), and salts of such isomers, whenever
the existence of such salts, isomers, and salts of isomers is possible.
Fenfluramine (1670).
(e) Stimulants. Unless specifically excepted in a rule adopted by the board or
unless listed in another schedule, any material, compound, mixture, or
preparation which contains any quantity of the following substances having a
stimulant effect on the central nervous system, including its salts, isomers
(whether optical, position, or geometric), and salts of such isomers whenever
the existence of such salts, isomers, and salts of isomers is possible within
the specific chemical designation:
(1) Diethylpropion (1608).
(2) Mazindol (1605).
(3) Phentermine (1640).
(4) Pemoline (including organometallic complexes and chelates thereof)
(1530).
(5) Pipradrol (1750).
(6) SPA ((-)-1-dimethylamino-1,2-diphenylethane (1635).
(f) Other substances. Unless specifically excepted or unless listed in another
schedule, any material, compound, mixture, or preparation which contains any
quantity of the following substances including its salts:
(1) Pentazocine (9709).
(g) The board may except by rule any compound, mixture, or preparation
containing any depressant substance listed in subsection (b), (c), (d), (e), or (f)
from the application of any part of this article if the compound, mixture, or
preparation contains one (1) or more active medicinal ingredients not having a
depressant effect on the central nervous system, and if the admixtures are
included therein in
combinations, quantity, proportion, or concentration that vitiate the potential for
abuse of the substances which have a depressant effect on the central nervous
system.
As added by Acts 1976, P.L.148, SEC.7. Amended by Acts 1977, P.L.344,
SEC.2; Acts 1979, P.L.303, SEC.6; Acts 1981, P.L.170, SEC.5; P.L.333-1983,
SEC.4; P.L.77-1984, SEC.14; P.L.200-1987, SEC.12; P.L.288-2001, SEC.17;
P.L.8-2004, SEC.3.